Combined COVID-19 and Flu Test Authorized for Point-of-Care Use
- PMID: 36594962
- DOI: 10.1001/jama.2022.23890
Combined COVID-19 and Flu Test Authorized for Point-of-Care Use
Similar articles
-
Clinical Evaluation of BD Veritor SARS-CoV-2 and Flu A+B Assay for Point-Of-Care System.Microbiol Spectr. 2022 Apr 27;10(2):e0180721. doi: 10.1128/spectrum.01807-21. Epub 2022 Apr 12. Microbiol Spectr. 2022. PMID: 35412847 Free PMC article.
-
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.J Clin Microbiol. 2021 Feb 18;59(3):e02955-20. doi: 10.1128/JCM.02955-20. Print 2021 Feb 18. J Clin Microbiol. 2021. PMID: 33298613 Free PMC article.
-
European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test.J Med Virol. 2021 Oct;93(10):5798-5804. doi: 10.1002/jmv.27111. Epub 2021 Jun 6. J Med Virol. 2021. PMID: 34050951 Free PMC article.
-
Immunochromatography-Application Example and POCT Type Genetic Testing.Chem Pharm Bull (Tokyo). 2021;69(10):984-988. doi: 10.1248/cpb.c21-00164. Chem Pharm Bull (Tokyo). 2021. PMID: 34602580 Review.
-
Influenza and COVID-19: What does co-existence mean?Influenza Other Respir Viruses. 2021 May;15(3):407-412. doi: 10.1111/irv.12824. Epub 2020 Oct 31. Influenza Other Respir Viruses. 2021. PMID: 33128444 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
